Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Postural Orthostatic Tachycardia Syndrome (POTS)
Locations
- Mercy Gilbert Medical Center, Gilbert, Arizona, United States
- North County Neurology Associates, Carlsbad, California, United States
- Stanford University, Palo Alto, California, United States
- Southern California Heart Specialists, Pasadena, California, United States
- Yale University, New Haven, Connecticut, United States
- Innovative Research of West Florida, Inc., Clearwater, Florida, United States
- Indiana University Health Neuroscience Center, Indianapolis, Indiana, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Saint Luke's MidAmerica Heart Institute, Kansas City, Missouri, United States
- New York University Langone, New York, New York, United States
- Columbia University, New York, New York, United States
- University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- University of Texas Southwestern, Dallas, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
- University of Calgary, Calgary, Alberta, Canada
- University of Alberta Hospital, Edmonton, Alberta, Canada